KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Sales (2016 - 2025)

Historic Return on Sales for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Q3 2025 value amounting to 0.23%.

  • Supernus Pharmaceuticals' Return on Sales fell 4500.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.11% for FY2024, which is 1100.0% up from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Return on Sales stood at 0.23% for Q3 2025, which was down 4500.0% from 0.14% recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Return on Sales peaked at 0.22% during Q3 2024, and registered a low of 0.23% during Q3 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' median Return on Sales value was 0.05% (recorded in 2022), while the average stood at 0.05%.
  • Per our database at Business Quant, Supernus Pharmaceuticals' Return on Sales soared by 3200bps in 2024 and then tumbled by -4500bps in 2025.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Return on Sales stood at 0.02% in 2021, then surged by 892bps to 0.15% in 2022, then tumbled by -95bps to 0.01% in 2023, then soared by 1135bps to 0.09% in 2024, then crashed by -366bps to 0.23% in 2025.
  • Its last three reported values are 0.23% in Q3 2025, 0.14% for Q2 2025, and 0.08% during Q1 2025.